Importer of Controlled Substances; Notice of Application, 19594 [E9-9778]
Download as PDF
<![CDATA[
pwalker on PROD1PC71 with NOTICES
19594
Federal Register / Vol. 74, No. 81 / Wednesday, April 29, 2009 / Notices
presentations should attend a
prehearing conference to be held at 9:30
a.m. on May 28, 2009 at the U.S.
International Trade Commission
Building. Oral testimony and written
materials to be submitted at the hearing
are governed by sections 201.6(b)(2) and
201.13(f) of the Commission’s rules.
Written submissions.—Each party is
encouraged to submit a prehearing brief
to the Commission. The deadline for
filing prehearing briefs is May 28, 2009.
Parties may also file posthearing briefs.
The deadline for filing posthearing
briefs is June 8, 2009. In addition, any
person who has not entered an
appearance as a party to the
investigation may submit a written
statement of information pertinent to
the consideration of market disruption
or threat thereof and/or remedy on or
before June 8, 2009. Parties may submit
final comments on market disruption on
or before June 16, 2009 and on remedy
on or before June 24, 2009. Final
comments shall contain no more than
ten (10) double-spaced and single-sided
pages of textual material. All written
submissions must conform with the
provisions of section 201.8 of the
Commission’s rules; any submissions
that contain confidential business
information must also conform with the
requirements of section 201.6 of the
Commission’s rules. The Commission’s
rules authorize filing submissions with
the Secretary by facsimile or electronic
means only to the extent permitted by
section 201.8 of the rules (see Handbook
for Electronic Filing Procedures, https://
www.usitc.gov/secretary/
fed_reg_notices/rules/documents/
handbook_on_electronic_filing.pdf).
Persons with questions regarding
electronic filing should contact the
Secretary (202–205–2000).
In accordance with section 201.16(c)
of the Commission’s rules, each
document filed by a party to the
investigation must be served on all other
parties to the investigation (as identified
by the service list), and a certificate of
service must be timely filed. The
Secretary will not accept a document for
filing without a certificate of service.
Remedy.—No separate hearing on the
issue of remedy will be held. Those
parties wishing to present arguments on
the issue of remedy may do so orally at
the hearing or in their prehearing or
posthearing briefs or other written
submissions.
Authority: This investigation is being
conducted under the authority of section 421
of the Trade Act of 1974; this notice is
published pursuant to section 206.3 of the
Commission’s rules.
VerDate Nov<24>2008
17:48 Apr 28, 2009
Jkt 217001
By order of the Commission.
Marilyn R. Abbott,
Secretary to the Commission.
Issued: April 24, 2009.
William R. Bishop,
Acting Secretary to the Commission.
[FR Doc. E9–9760 Filed 4–28–09; 8:45 am]
a registration under this Section to a
bulk manufacturer of a controlled
substance in schedule I or II, and prior
to issuing a regulation under 21 U.S.C.
952(a)(2) authorizing the importation of
such a substance, provide
manufacturers holding registrations for
the bulk manufacture of the substance
BILLING CODE P
an opportunity for a hearing.
Therefore, in accordance with Title 21
DEPARTMENT OF JUSTICE
Code of Federal Regulations
§ 1301.34(a), this is notice that on
Drug Enforcement Administration
February 20, 2009, Meridian Medical
Technologies, 2555 Hermelin Drive, St.
Importer of Controlled Substances;
Louis, Missouri 63144, made
Notice of Application
application by renewal to the Drug
This is notice that on March 10, 2009, Enforcement Administration (DEA) to
Penick Corporation, 33 Industrial Park
be registered as an importer of
Road, Pennsville, New Jersey 08070,
Morphine (9300), a basic class of
made application by renewal to the
controlled substance listed in schedule
Drug Enforcement Administration
II.
(DEA) for registration as an importer of
The company plans to import
the basic classes of controlled
products for research experimentation
substances listed in schedule II.
or clinical use and analytical testing.
Drug
Schedule
Any bulk manufacturer who is
presently, or is applying to be,
Coca Leaves (9040) .....................
II
Raw Opium (9600) .......................
II registered with DEA to manufacture
Poppy Straw (9650) ......................
II such basic class of controlled substance
may file comments or objections to the
Concentrate of Poppy Straw
(9670) ........................................
II issuance of the proposed registration
and may, at the same time, file a written
The company plans to import the
request for a hearing on such
listed controlled substances to
application pursuant to 21 CFR 1301.43
manufacture bulk controlled substance
and in such form as prescribed by 21
intermediates for sale to its customers.
CFR 1316.47.
As noted in a previous notice
Any such comments or objections
published in the Federal Register on
being sent via regular mail should be
September 23, 1975 (40 FR 43745), all
addressed, in quintuplicate, to the Drug
applicants for registration to import a
Enforcement Administration, Office of
basic class of any controlled substances
in schedule I or II are, and will continue Diversion Control, Federal Register
to be, required to demonstrate to the
Representative (ODL), 8701 Morrissette
Deputy Assistant Administrator, Office
Drive, Springfield, Virginia 22152; and
of Diversion Control, Drug Enforcement must be filed no later than May 29,
Administration, that the requirements
2009.
for such registration pursuant to 21
This procedure is to be conducted
U.S.C. 958(a); 21 U.S.C. 823(a); and 21
simultaneously with, and independent
CFR 1301.34(b), (c), (d), (e), and (f) are
of, the procedures described in 21 CFR
satisfied.
1301.34(b), (c), (d), (e), and (f). As noted
Dated: April 17, 2009.
in a previous notice published in the
Joseph T. Rannazzisi,
Federal Register on September 23, 1975
Deputy Assistant Administrator, Office of
(40 FR 43745–46), all applicants for
Diversion Control, Drug Enforcement
registration to import a basic class of
Administration.
any controlled substance listed in
[FR Doc. E9–9778 Filed 4–28–09; 8:45 am]
schedule I or II are, and will continue
BILLING CODE 4410–09–P
to be, required to demonstrate to the
Deputy Assistant Administrator, Office
of Diversion Control, Drug Enforcement
DEPARTMENT OF JUSTICE
Administration, that the requirements
for such registration pursuant to 21
Drug Enforcement Administration
U.S.C. 958(a), 21 USC § 823(a), and 21
Importer of Controlled Substances;
CFR 1301.34(b), (c), (d), (e), and (f) are
Notice of Application
satisfied.
Pursuant to 21 U.S.C. 958(i), the
Attorney General shall, prior to issuing
PO 00000
Frm 00110
Fmt 4703
Sfmt 4703
E:\FR\FM\29APN1.SGM
29APN1
]]>Agencies
[Federal Register Volume 74, Number 81 (Wednesday, April 29, 2009)]
[Notices]
[Page 19594]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-9778]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Application
This is notice that on March 10, 2009, Penick Corporation, 33
Industrial Park Road, Pennsville, New Jersey 08070, made application by
renewal to the Drug Enforcement Administration (DEA) for registration
as an importer of the basic classes of controlled substances listed in
schedule II.
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Coca Leaves (9040)........................................... II
Raw Opium (9600)............................................. II
Poppy Straw (9650)........................................... II
Concentrate of Poppy Straw (9670)............................ II
------------------------------------------------------------------------
The company plans to import the listed controlled substances to
manufacture bulk controlled substance intermediates for sale to its
customers.
As noted in a previous notice published in the Federal Register on
September 23, 1975 (40 FR 43745), all applicants for registration to
import a basic class of any controlled substances in schedule I or II
are, and will continue to be, required to demonstrate to the Deputy
Assistant Administrator, Office of Diversion Control, Drug Enforcement
Administration, that the requirements for such registration pursuant to
21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR 1301.34(b), (c), (d),
(e), and (f) are satisfied.
Dated: April 17, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E9-9778 Filed 4-28-09; 8:45 am]
BILLING CODE 4410-09-P
